Fonds NutsOhra
12
0
1
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
17%
2 trials in Phase 3/4
9%
1 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Specturi Device - Feasibility Study
Role: collaborator
A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients
Role: collaborator
SANICS II Trial: Stimulation of the Autonomic Nervous System in Colorectal Surgery by Perioperative Nutrition
Role: collaborator
Systems of Underprivileged Preschoolers in Their Home and Preschool EnviRonment: Family Intervention Trial
Role: collaborator
Implantology and Sjögren's Syndrome
Role: collaborator
2B Active: Outpatient Rehabilitation for Adolescents With Chronic Pain
Role: collaborator
Pulmonary Rehabilitation: Effects on Cognitive Functioning, Mood, Anxiety, and Quality of Life in Patients With COPD
Role: collaborator
CBT for Patients With Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders
Role: collaborator
Cardiac Arrhythmias in Epilepsy: the CARELINK-study
Role: collaborator
N-Acetylcysteine in Patients With Sickle Cell Disease
Role: collaborator
Prenatal Counseling in Extreme Prematurity: Parents' View
Role: collaborator
Effects of Rapid Genetic Counseling and Testing in Newly Diagnosed Breast Cancer Patients
Role: collaborator
All 12 trials loaded